FDA vaccine adviser offers stark take on new Covid booster: ‘Healthy young person unlikely to benefit’

The minimal risk of COVID to young people has all but faded away, but the continued threat from the public-private partnership between government agencies and Big Pharma propagandizing the need for endless boosters has remained unrelenting.

National Institute of Allergy and Infectious Diseases’ (NIAID) outgoing director Dr. Anthony Fauci and Centers for Disease Control and Prevention director Rochelle Walensky have often touted The Science™ as a basis for their incessant promotion of jabs for all. Throughout the pandemic and beyond they have continued to ignore the cautions of the Food and Drug Administration’s (FDA) Vaccine Advisory Committee and recently committee member Dr. Paul Offit has used multiple outlets to once again warn there’s no “clear evidence of benefit” for young people and COVID shots.

Offit, who also serves as the director of the Vaccine Education Center at the Children’s Hospital of Philadelphia joined CNN to pose the question, “Who really benefits from another dose?”

And  his denouncement of boosters for young people stood in stark contrast to the heavily produced advertisements bereft of the typical warnings that pharmaceutical commercials are inundated with.

“A healthy young person is unlikely to benefit from a booster dose,” Offit said on CNN as he and the FDA advisory board have opposed providing shots to anyone other than the most vulnerable and groups older than 65 years old because the data has never supported it.

As he wrote in the Wall Street Journal Wednesday, “only a select group are likely to benefit” from the new bivalent shot that reportedly combines an original strain of the COVID virus along with parts of recent BA.4 and BA.5 subvariants, “and the evidence to date doesn’t support the view that a bivalent vaccine containing omicron or its subvariants is better than the monovalent vaccine.”

“The CDC risks eroding the public’s trust by overselling the new shot,” Offit wrote further.

“Why not get it?” the doctor was asked on CNN as corporate media has continued to ignore adverse reactions to jabs. To that, he replied with the reality that there was no available human data to assert that there questionable benefit could outweigh the risks. At launch, the bivalent booster had only been tested on mice and previous versions of the shot have been connected to rising cases of myocarditis and other serious medical complications for young people.

“If there’s not clear evidence of benefit, then it’s not fair to ask people to take a risk no matter how small. The benefit should be clear,” the doctor explained.

As Kentucky Sen. Rand Paul (R) said in the same hearing where he confronted Dr. Anthony Fauci over “flawed science,” the basis for promoting additional boosters appeared to be coming solely from the fact that doing so would produce antibodies.

“[U.S. federal health agencies] only report that if you give [children] the jab, they’ll make antibodies and you can give kids hundreds of jabs and they’ll make antibodies every time but that does not prove efficacy,” Paul asserted before calling out Fauci for “denying the very fundamental premise of immunology that previous infection does provide some sort of immunity.”

“Right now,” Offit who once again voted against FDA approval of another round of boosters, said, “they’re saying we should trust mouse data and I don’t think that should ever be true.”


Please help us! If you are fed up with letting radical big tech execs, phony fact-checkers, tyrannical liberals and a lying mainstream media have unprecedented power over your news please consider making a donation to BPR to help us fight them. Now is the time. Truth has never been more critical!

Success! Thank you for donating. Please share BPR content to help combat the lies.
Kevin Haggerty


We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. If a comment is spam, instead of replying to it please click the ∨ icon below and to the right of that comment. Thank you for partnering with us to maintain fruitful conversation.

PLEASE JOIN OUR NEW COMMENT SYSTEM! We love hearing from our readers and invite you to join us for feedback and great conversation. If you've commented with us before, we'll need you to re-input your email address for this. The public will not see it and we do not share it.

Latest Articles